Competition Heats Up in Healthcare: Compliance and Data Standards are Key

Details

Major tech companies such as Apple and Google are rapidly expanding from consumer electronics into smart healthcare. The core of the competition has shifted from hardware specifications to achieving 'medical compliance.' Currently, Apple Watch leads with multiple FDA Software as a Medical Device (SaMD) certifications but faces patent litigation challenges from companies like Masimo. Regarding regulations, there is polarization: the US FDA suggests a flexible mechanism favoring market-led innovation ('market first, regulate later'), contrasting sharply with strict thresholds like the EU AI Act. In Taiwan, the passage of the Regenerative Medicine Dual Law and the promotion of FHIR international standards are establishing clear legal and technical pathways for the ICT industry to enter clinical systems. The underlying motive is transforming user data from mere records into 'assets with medical value,' enabling high-margin B2B markets and insurance actuarial services. Success requires more than just increasing sensor count; it demands robust compliance architecture and federated learning capabilities that address global trends toward 'data localization' and 'data sovereignty.' Ultimately, the key differentiator is the ability to solve the last mile problem—connecting data to the medical system—and converting compliance capability into an irreplaceable competitive advantage. These developments are highly relevant for Japan's healthcare IT industry, emphasizing the need for international standardization adherence and regulatory understanding.